- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03000699
Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction
January 29, 2019 updated by: Lena Quilty, Centre for Addiction and Mental Health
The purpose of this study is to determine whether computer bias modification for interpretation bias (CBM-I) is effective in the reduction of suicidal ideation in substance use disorders.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Eighty-eight adult inpatients completing residential treatment in the Addictions Services at the Centre for Addiction and Mental Health (CAMH) will be randomized to receive CBM-I daily for one week, adjunct to the residential psychosocial treatment or to an assessment-only control condition.
Participants will complete clinical measures consisting of interviews and questionnaires measuring suicidal ideation, hopelessness, depression, negative affect, and interpretation biases before, during and after treatment.
Study Type
Interventional
Enrollment (Actual)
88
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 1R8
- Centre for Addiction and Mental Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Exhibit moderate suicide risk or greater
- Be enrolled in the Addictions Services inpatient program
- Fluent in reading English
- Capacity to give informed consent
Exclusion Criteria:
- A lifetime diagnosis of a psychotic or bipolar disorder
- Significant neurological disorder or psychical illness likely to interfere with participation
- Psychotropic medication changes within the past two weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Bias Modification
64 training paragraphs, approximately 10-20 seconds each, digitally recorded and presented stereophonically through headphones, delivered over the course of one week.
|
Training paragraphs describe scenarios designed to be ambiguous at the outset and to resolve in a positive direction, with the intention of establishing a learning contingency between the ambiguity at the beginning of the scenario and the positive resolution that becomes clear towards the end of the statement.
|
No Intervention: Assessment-Only Control
No training will be provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Columbia-Suicide Severity Rating Scale, Screen Version (C-SSRS)
Time Frame: Seven days
|
This scale quantifies the severity of suicidal ideation and behaviour.
|
Seven days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Beck Hopelessness Scale (BHS)
Time Frame: Seven days
|
This questionnaire assesses thoughts and emotions associated with the future.
|
Seven days
|
Beck Depression Inventory II (BDI-II)
Time Frame: Seven days
|
This questionnaire assesses severity of depressive symptoms and cognitions.
|
Seven days
|
Positive and Negative Affect Schedule (PANAS)
Time Frame: Seven days
|
This questionnaire assesses current positive and negative mood
|
Seven days
|
Scrambled Sentences Tests
Time Frame: Seven days
|
This computer test will be used as an implicit measure of negative interpretation bias.
|
Seven days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Lena C Quilty, PhD, Centre for Addiction and Mental Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2017
Primary Completion (Actual)
October 1, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
December 20, 2016
First Submitted That Met QC Criteria
December 20, 2016
First Posted (Estimate)
December 22, 2016
Study Record Updates
Last Update Posted (Actual)
January 30, 2019
Last Update Submitted That Met QC Criteria
January 29, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 077/2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Dependence
-
Medical University InnsbruckCompletedSubstance Abuse | Nicotine Dependence | Tobacco Dependence | Substance DependenceAustria
-
Merck Sharp & Dohme LLCCompletedOpiate Dependence | Substance Dependence | Drug Dependence
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA); University of Toronto; RTI InternationalCompletedSubstance Abuse, Intravenous | HIV | Heroin Dependence | Opioid Dependence | Cocaine Dependence | Amphetamine DependenceUnited States
-
University of CincinnatiNational Institute on Drug Abuse (NIDA); MaryhavenUnknownHeroin Dependence | Opiate Dependence | Substance DependenceUnited States
-
California Pacific Medical Center Research InstituteUnknownSubstance Dependence | Amphetamine DependenceUnited States
-
Central Hospital, Nancy, FranceHospital of Jury-les-Metz, France; Healthcare Center of Accompaniment and Prevention...UnknownAlcoholism | Opiate Dependence | Early Satisfaction With Substance Dependence CareFrance
-
University of WashingtonU.S. Army Medical Research and Development CommandCompletedAlcohol Dependence | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
GlaxoSmithKlineWithdrawnAlcohol Dependence | Substance Dependence
-
Macmillan Research Group UKNMP Medical Research Institute; Warwick Research ServicesCompletedAlcohol Dependence | Substance Use Disorder | Drug Dependence,India
-
Rajmonda Nallbani-KomoniUnknownAnalgesic Drug DependenceKosovo
Clinical Trials on Cognitive Bias Modification
-
Istanbul Sabahattin Zaim UniversityCompletedPerfectionism | Intolerance to UncertaintyUnited States
-
Temple UniversityNot yet recruiting
-
Universidad Complutense de MadridCompletedDepression | Cognitive ChangeSpain
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioSuspended
-
King's College LondonSouth London and Maudsley NHS Foundation Trust; South West London and St George... and other collaboratorsUnknownEating Disorders in AdolescenceUnited Kingdom
-
University of SouthamptonEconomic and Social Research Council, United KingdomCompletedChronic Pain | Musculoskeletal Pain DisorderUnited Kingdom
-
Dokuz Eylul UniversityThe Scientific and Technological Research Council of TurkeyCompletedObsessive-compulsive Disorders and Symptoms | Obsessive Thoughts | Obsessive Compulsive BehaviorTurkey
-
Ruhr University of BochumUniversity Hospital, EssenCompleted
-
Mclean HospitalRecruitingObsessive-Compulsive DisorderUnited States
-
Ruhr University of BochumLudwig-Maximilians - University of MunichCompleted